An Open-Label, Multicentre, Single Arm Phase II Study Of Oral GW572016 As Single Agent Therapy In Subjects With Advanced Or Metastatic Breast Cancer Who Have Progressed While Receiving Herceptin-Containing Regiments

Short title	An Open-Label, Multicentre, Single Arm Phase II Study Of Oral GW572016 As Single Agent Therapy In Subjects With Advanced Or Metastatic Breast Cancer Who Have Progressed While Receiving Herceptin-Containing Regiments
Status	Finished
Effective start/end date	1/04/04 → 31/03/07

Project Details